Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-4-17
pubmed:abstractText
Explore relationships between 12 dopamine D2 gene variants and quantitative measures of positive and negative symptom response following clozapine treatment in two treatment refractory or intolerant populations (Caucasian and African-American).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0924-977X
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
248-59
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16278074-Adult, pubmed-meshheading:16278074-African Americans, pubmed-meshheading:16278074-Alleles, pubmed-meshheading:16278074-Antipsychotic Agents, pubmed-meshheading:16278074-Clozapine, pubmed-meshheading:16278074-Demography, pubmed-meshheading:16278074-European Continental Ancestry Group, pubmed-meshheading:16278074-Female, pubmed-meshheading:16278074-Gene Frequency, pubmed-meshheading:16278074-Genetic Variation, pubmed-meshheading:16278074-Haplotypes, pubmed-meshheading:16278074-Humans, pubmed-meshheading:16278074-Linkage Disequilibrium, pubmed-meshheading:16278074-Male, pubmed-meshheading:16278074-Psychiatric Status Rating Scales, pubmed-meshheading:16278074-Receptors, Dopamine D2, pubmed-meshheading:16278074-Schizophrenia, pubmed-meshheading:16278074-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.
pubmed:affiliation
Neurogenetics Section, Centre for Addiction and Mental Health, University of Toronto, 250 College Street, Toronto, Ontario M5T 1R8, Canada.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural